chronic idiopathic thrombocytopenic purpura

chronic idiopathic thrombocytopenic purpura.

References in periodicals archive ?
Bansal D, Bhamare TA, Trehan A, Ahluvalia J, Varma N, Marwaha RK, Outcome of Chronic Idiopathic Thrombocytopenic Purpura in Children.
It also lessened the need for rescue medications and concomitant medications in patients with chronic idiopathic thrombocytopenic purpura (ITP) not responsive to previous therapy.
Berchtold P, McMillan R: Therapy of chronic idiopathic thrombocytopenic purpura in adults.
Food and Drug Administration has extended the priority review period for GlaxoSmithKline's (GSK) New Drug Application (NDA) for PROMACTA[R] (eltrombopag) for the short-term treatment of chronic idiopathic thrombocytopenic purpura (ITP).
June 20 /PRNewswire-FirstCall/ -- GlaxoSmithKline today announced that the United States Food and Drug Administration has extended the priority review period for PROMACTA(R) (eltrombopag) for the short-term treatment of previously treated patients with chronic idiopathic thrombocytopenic purpura, as they require more time to review the application.
Eradication of Helicobacter pylori significantly improves platelet counts in patients with chronic idiopathic thrombocytopenic purpura, reported Takayoshi Suzuki, M.
Julia A, Araguas C, Rossello J, et al: Lack of useful clinical predictors of response to splenectomy in patients with chronic idiopathic thrombocytopenic purpura (ITP).
PHILADELPHIA and LONDON, March 3 /PRNewswire-FirstCall/ -- GlaxoSmithKline today announced that the United States Food and Drug Administration has granted Priority Review for PROMACTA(R) (eltrombopag) for the short-term treatment of patients with chronic idiopathic thrombocytopenic purpura (ITP).
Application Data Show PROMACTA Significantly Raised Platelet Counts and Lowered Bleeding Risk in Clinical Trials for the Short-Term Treatment of Patients with Chronic Idiopathic Thrombocytopenic Purpura (ITP)
Data from this study showed that PROMACTA at 50-75mg once daily resulted in a statistically significant increase in platelet counts and also reduced bleeding in adult patients with chronic idiopathic thrombocytopenic purpura (ITP).

Full browser ?